May 10 was a bad day for small companies trying to make it big with abuse deterrent opioid formulations.
The day began with Pain Therapeutics Inc. and Durect Corp. releasing copies of a letter they had received from their Big Pharma partner, Pfizer Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?